| 2020 | A Population Pharmacokinetic and Pharmacodynamic Model of CKD-519
| PHARMACEUTICS |
| 2024 | Assessment of Pharmacokinetic Effects of Herbal Medicines on Escitalopram
| THERAPEUTICS AND CLINICAL RISK MANAGEMENT |
| 2018 | Coagulant Effect and Tolerability of Yeast-Produced Recombinant Batroxobin in Healthy Adult Subjects | CLINICAL DRUG INVESTIGATION |
| 2018 | Comparison of biosimilar filgrastim with a reference product: pharmacokinetics, pharmacodynamics, and safety profiles in healthy volunteers
| DRUG DESIGN DEVELOPMENT AND THERAPY |
| 2017 | Comparison of Pharmacokinetics and Safety of a Fixed-dose Combination of Rosuvastatin and Ezetimibe Versus Separate Tablets in Healthy Subjects | CLINICAL THERAPEUTICS |
| 2021 | Comparison of the pharmacokinetics and pharmacodynamics of YH4808 in healthy subjects for defining an appropriate dosing regimen
| Translational and Clinical Pharmacology |
| 2017 | Decreased potency of fimasartan in liver cirrhosis was quantified using mixed-effects analysis
| Translational and Clinical Pharmacology |
| 2014 | Effect of Ketoconazole on Lobeglitazone Pharmacokinetics in Korean Volunteers | CLINICAL THERAPEUTICS |
| 2022 | Effect of Rifampicin on the Pharmacokinetics of Evogliptin in Healthy Volunteers
| DRUG DESIGN DEVELOPMENT AND THERAPY |
| 2022 | Effects of Hepatic Impairment on the Pharmacokinetic Profile and Safety of Lobeglitazone | CLINICAL PHARMACOLOGY IN DRUG DEVELOPMENT |
| 2016 | Effects of JOINS® on the pharmacokinetic profiles of aceclofenac in healthy Korean volunteers: an open-label, multiple-dose, one sequence, two-period study
| Translational and Clinical Pharmacology |
| 2023 | Evaluation of pharmacokinetic interactions between lobeglitazone, empagliflozin, and metformin in healthy subjects
| Translational and Clinical Pharmacology |
| 2014 | First-in-human study with new recombinant agalsidase beta (ISU303) in healthy subjects | JOURNAL OF CLINICAL PHARMACOLOGY |
| 2013 | Impact of ABCC2, ABCG2 and SLCO1B1 polymorphisms on the pharmacokinetics of pitavastatin in humans
| DRUG METABOLISM AND PHARMACOKINETICS |
| 2012 | Influence of ABCC2, SLCO1B1, and ABCG2 Polymorphisms on the Pharmacokinetics of Olmesartan | JOURNAL OF CARDIOVASCULAR PHARMACOLOGY |
| 2013 | Influence of Hepatic Dysfunction on the Pharmacokinetics and Safety of Fimasartan | JOURNAL OF CARDIOVASCULAR PHARMACOLOGY |
| 2020 | Pharmacodynamic evaluation of YH4808 for Helicobacter pylori eradication in healthy subjects
| Translational and Clinical Pharmacology |
| 2023 | Pharmacokinetic and pharmacodynamic drug-drug interactions between evogliptin and empagliflozin or dapagliflozin in healthy male volunteers
| Clinical and Translational Science |
| 2023 | Pharmacokinetic and pharmacodynamic interaction of DWP16001, a sodium-glucose cotransporter-2 inhibitor, with phentermine in healthy subjects | Expert Opinion on Drug Metabolism & Toxicology |
| 2017 | Pharmacokinetic drug interaction between atorvastatin and ezetimibe in healthy Korean volunteers
| Transl Clin Pharmacol |
| 2015 | Pharmacokinetic Interaction Between Amlodipine and Lobeglitazone, a Novel Peroxisome Proliferator–activated Receptor-γ Agonist, in Healthy Subjects | CLINICAL THERAPEUTICS |
| 2017 | Pharmacokinetic interactions between glimepiride and rosuvastatin in healthy Korean subjects: does the SLCO1B1 or CYP2C9 genetic polymorphism affect these drug interactions? Observations and introspection of the bioanalysis
| DRUG DESIGN DEVELOPMENT AND THERAPY |
| 2024 | Pharmacokinetic Modeling of Bepotastine for Determination of Optimal Dosage Regimen in Pediatric Patients with Allergic Rhinitis or Urticaria
| PHARMACEUTICS |
| 2021 | Pharmacokinetics and safety of evogliptin in hepatically impaired patients | BRITISH JOURNAL OF CLINICAL PHARMACOLOGY |
| 2016 | Pharmacokinetics, pharmacodynamics and safety of CKD-519, a CETP inhibitor, in healthy subjects
| DRUG DESIGN DEVELOPMENT AND THERAPY |
| 2024 | Population pharmacokinetic-pharmacodynamic modeling of clopidogrel for dose regimen optimization based on CYP2C19 phenotypes: A proof of concept study
| CPT-PHARMACOMETRICS & SYSTEMS PHARMACOLOGY |
| 2023 | The effects of long-term cumulative HbA1c exposure on the development and onset time of dementia in the patients with type 2 diabetes mellitus: Hospital based retrospective study (2005-2021) | DIABETES RESEARCH AND CLINICAL PRACTICE |
| 2019 | The safety, pharmacodynamics, and pharmacokinetics of immediate-release formulation containing esomeprazole 20 mg/sodium bicarbonate 800 mg in healthy adult male
| Drug Design, Development and Therapy |
| 2009 | 복부초음파 수검자에서 담낭용종의 유병률
| Korean Journal of Family Medicine (가정의학회지) |
